Articles for tag: depression, DMT, medication, psychiatry, research, risk, treatment

The Clinical Viability of Tryptamine-Based Pharmacotherapy for Major Depressive and Mood Disorders

The field of mental health treatment is witnessing a surge of interest in psychedelic compounds, and Dimethyltryptamine (DMT) is at the forefront of this movement. However, for those following the headlines, it is essential to understand the current status: DMT-based medicines are not yet approved or commercially available. Research into these powerful compounds, particularly the ultra-short-acting analogue 5-MeO-DMT, is still in the mid-stage of clinical testing (Phase 2).   Despite being unapproved, the research is moving quickly. One leading candidate, ...

The Digital Blind Spot and an Unmanageable Risk

The discourse surrounding internet access in secure hospitals is often framed as a simple balance between rehabilitative opportunity and potential risk. The benefits are self-evident and align with the core principles of recovery. They include maintaining family ties, managing personal affairs, and preparing for a digital society. This article, however, argues that this framing is now dangerously obsolete. The critical issue is no longer whether patients should have access to the internet. Instead, it is the stark reality that we ...

Upward bullying: under-recognised in health services

When people speak of ‘bullying’ at the workplace unknowingly they are referring to one type of bullying, called “downward bullying.” This is where a person in a position of authority abuses their power usually to suborodinate workers or those are a similar level. A growing body of evidence suggests that bullying can also flow in the opposite direction. This phenomenon, known as “upward bullying,” occurs when subordinates engage in repeated aggressive or disrespectful behaviours towards their superiors, undermining their authority ...

Seductive Epistemic Oversimplification and the Charismatic TEDification of Psychiatry

In an era of TED Talks and trauma-informed evangelism, the public understanding of complex clinical phenomena is increasingly shaped by by emotionally compelling narratives instead of peer-reviewed evidence. Figures like Johann Hari and Gabor Maté have become cultural touchstones—revered not for their methodological rigour, but for their ability to reframe suffering in ways that feel intuitively true. The result is a widespread phenomenon we might call epistemic oversimplification, amplified by narrative seduction. The author and this site now coins the ...

Clozapine-Associated Cardiac Pathologies

Clozapine, an atypical antipsychotic medication, is widely recognised as the most effective treatment for individuals with treatment-resistant schizophrenia (TRS).1 Approved in 1989, its utilisation has grown, particularly for patients who have not responded adequately to other antipsychotic agents.3 Despite its superior therapeutic efficacy, clozapine carries a significant cautionary “black box warning” due to its association with rare but serious adverse effects, most notably agranulocytosis, but also considerable cardiovascular risks.5 It is important to note that, despite these risks, population-level studies ...

Clozapine – including lessons from the Coroner

Clozapine is a unique antipsychotic medication that plays a crucial role in treating severe mental health conditions. It is the only drug proven effective for treatment-resistant schizophrenia, offering hope to patients who have not responded to other treatments. See also: Treatment Resistant Schizophrenia. However, its use comes with strict monitoring requirements due to potential serious side effects, including risks to blood health and the heart. This article explores clozapine’s licenced and unlicenced uses, its historical development, and the protocols for ...

Bonkers medicine in India

The bedrock of modern medicine rests upon the firm principles of evidence-based practice and scientific rigour. Yet, across the global healthcare landscape, unsettling developments frequently expose the considerable vulnerability of these foundations to external pressures. Recent policy decisions in India, particularly concerning the integration of allopathic medicine with homeopathy, serve as a stark and disquieting case study. These compel a critical examination of how socio-political forces can decisively outweigh scientific consensus. This intricate interplay carries substantial implications especially for psychiatry; ...

Responsibility and consultant psychiatrists

Responsibility in healthcare extends far beyond individual clinical decision-making. For consultant psychiatrists working within multidisciplinary teams, responsibility encompasses clinical leadership, professional accountability, ethical decision-making, and the complex navigation of professional boundaries. This article explores the dimensions of responsibility for consultant psychiatrists in general, and forensic psychiatry settings. It is examined how these responsibilities manifest within the collaborative framework of modern mental health services. Sound psychiatric practice within the NHS and other health systems necessitates a deep understanding of responsibility. This ...

Recruitment and retention of consultant forensic psychiatrists in the UK

The recruitment and retention of experienced Consultant Forensic Psychiatrists present a critical challenge for the National Health Service (NHS) and private sector health service. This highly specialised field demands a unique skill set and a particular understanding of the interface between mental health, legal systems, prison systems and the courts. The factors that attract a consultant to a post are often the very same ones that encourage long-term commitment and retention. High vacancy rates and reliance on locum staff within ...

Drug Holidays: Clinical Rationale, Risks, and Medico-Legal Considerations

This article addresses the concept of planned temporary, prolonged or permanent discontinuation of psychiatric medication. This is colloquially termed ‘drug holidays’, within the specific context of United Kingdom psychiatric practice. The primary focus is directed towards the significant medico-legal considerations inherent in such decisions, acknowledging the particular sensitivities and heightened risk environment encountered within psychiatry . The aim is to provide a comprehensive analysis for consultant psychiatrists navigating these complex clinical and legal intersections. The planned discontinuation of psychiatric medication ...